Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8981 |
High Similarity |
NPD5494 |
Approved |
0.8765 |
High Similarity |
NPD3818 |
Discontinued |
0.8758 |
High Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD1247 |
Approved |
0.8544 |
High Similarity |
NPD2801 |
Approved |
0.8375 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD919 |
Approved |
0.8323 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8313 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8284 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8263 |
Intermediate Similarity |
NPD7054 |
Approved |
0.825 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8224 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8214 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8214 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8182 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.816 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8144 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.807 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8059 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.805 |
Intermediate Similarity |
NPD920 |
Approved |
0.8039 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8038 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD37 |
Approved |
0.8024 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7975 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7949 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7941 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7941 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7879 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7879 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7875 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7871 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.787 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.787 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7862 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7799 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7744 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7727 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7702 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7683 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7673 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7611 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD943 |
Approved |
0.7547 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7528 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5242 |
Approved |
0.75 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2800 |
Approved |
0.75 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7468 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7443 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.744 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7378 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7358 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7349 |
Intermediate Similarity |
NPD1653 |
Approved |
0.734 |
Intermediate Similarity |
NPD5005 |
Approved |
0.734 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7321 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7321 |
Intermediate Similarity |
NPD6385 |
Approved |
0.731 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7308 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7303 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7285 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7278 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7273 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7241 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7239 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7233 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7211 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7211 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7211 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7202 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7197 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7173 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7173 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7167 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7159 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7151 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7127 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7127 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7108 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7062 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7045 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7037 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7013 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7011 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.701 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7006 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.699 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.699 |
Remote Similarity |
NPD7874 |
Approved |
0.6988 |
Remote Similarity |
NPD6190 |
Approved |
0.6983 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD7801 |
Approved |
0.6951 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6947 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6947 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6903 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6899 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD5978 |
Approved |
0.6897 |
Remote Similarity |
NPD5977 |
Approved |
0.6894 |
Remote Similarity |
NPD1613 |
Approved |
0.6894 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD2309 |
Approved |
0.6879 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6872 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6869 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6869 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD9268 |
Approved |
0.6859 |
Remote Similarity |
NPD2982 |
Phase 2 |
0.6859 |
Remote Similarity |
NPD2983 |
Phase 2 |
0.6859 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6829 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6828 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6826 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6825 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6825 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6825 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD6873 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD5890 |
Approved |
0.6821 |
Remote Similarity |
NPD5889 |
Approved |
0.6815 |
Remote Similarity |
NPD1876 |
Approved |
0.6806 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6795 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.679 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6788 |
Remote Similarity |
NPD6099 |
Approved |
0.6788
|
Remote Similarity |
NPD6100 |
Approved |